Please login to the form below

Not currently logged in
Email:
Password:

Accenture and BMS launch Indian pharmacovigilance centre

Accenture and Bristol-Myers Squibb (BMS) have launched a center for pharmacovigilance in Chennai, India.

Accenture and Bristol-Myers Squibb (BMS) have launched a center for pharmacovigilance in Chennai, India.

The new centre will process and code of adverse event data and generate regulatory periodic and aggregate reports on safety, as well as physician medical review of adverse events. Over 140 Accenture employees will run the site.

Pharmacovigilance involves monitoring safety data, assessment and reporting of potential side effects of approved medicines.

According to Accenture and BMS, the jv is the first of its kind involving a collaboration for 'end-to-end' safety case processing.

The team is organised as a parallel process and extension of the BMS pharmacovigilance headquarters' operations, which will handle data and reports between the two companies.

Part of a multi-year R&D agreement signed in April 2007, the jv will aid BMS's in its efforts to expand R&D operations in India as part of the company's global strategy.

Dr John Balian, senior vice-president of global pharmacovigilance and epidemiology at BMS, said: "Working with Accenture, we will continue to access world-class talent to deliver on our regulatory obligations, while enhancing our focus on patient safety."

Eric Sandor, managing director of Accenture Pharmacovigilance Services, added: "Through a truly collaborative partnership with BMS, we have established an industry leading operation that is delivering substantial efficiency and improved flexibility for the company's pharmacovigilance organisation."

30th September 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anatomy Health

We are a health information design consultancy focused on developing simple, accessible and inclusive patient communications. From evaluating existing patient...

Latest intelligence

Marketing to healthcare professionals – what’s the key ingredient missing from most campaigns?
What do you think is the difference between a campaign developed to win a share-of-mind with consumers and a campaign designed to gain the attention of healthcare professionals?...
What everyone forgets about good organisational change in pharma
Natasha Cowan speaks to Daphne Chung, Head of Organisational Transformation, to learn how she ensures smooth organisational change that takes all stakeholders into account....
Live from Singapore: Oncology in APAC - Evaluating the opportunity for novel therapies
Live webinar: Tuesday 11th December 2018,16:00 SGT / 17:00 JST...

Infographics